Asish Dasgupta

ORCID: 0000-0002-3670-1197
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Mitochondrial Function and Pathology
  • Pulmonary Hypertension Research and Treatments
  • ATP Synthase and ATPases Research
  • Phenothiazines and Benzothiazines Synthesis and Activities
  • Nitric Oxide and Endothelin Effects
  • RNA modifications and cancer
  • Ubiquitin and proteasome pathways
  • Essential Oils and Antimicrobial Activity
  • Metabolism and Genetic Disorders
  • Phytochemistry and Bioactivity Studies
  • Chemical synthesis and alkaloids
  • MicroRNA in disease regulation
  • Cardiomyopathy and Myosin Studies
  • Cardiovascular Function and Risk Factors
  • Cholinesterase and Neurodegenerative Diseases
  • Calcium signaling and nucleotide metabolism
  • COVID-19 Clinical Research Studies
  • Takotsubo Cardiomyopathy and Associated Phenomena
  • Nicotinic Acetylcholine Receptors Study
  • Cancer, Hypoxia, and Metabolism
  • Cellular transport and secretion
  • Quinazolinone synthesis and applications
  • Phosphodiesterase function and regulation
  • Antimicrobial Peptides and Activities
  • Atomic and Subatomic Physics Research

Queen's University
2015-2024

Institute of Medical Sciences
1992-2015

National Institute on Aging
2015

National Institutes of Health
2015

Jadavpur University
2004-2014

Rationale: Pulmonary arterial hypertension (PAH) often results in death from right ventricular failure (RVF). NLRP3 (nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3)-macrophage activation may promote RVF PAH. Objectives: Evaluating the contribution of inflammasome RV macrophages to PAH RVF. Methods: Rats with decompensated hypertrophy (monocrotaline [MCT] and Sugen-5416 hypoxia [SuHx]) were compared compensated rats (pulmonary artery banding)....

10.1164/rccm.202110-2274oc article EN American Journal of Respiratory and Critical Care Medicine 2022-06-14

Rationale: Pulmonary arterial hypertension (PAH) is an obstructive vasculopathy characterized by excessive pulmonary artery smooth muscle cell (PASMC) proliferation, migration, and apoptosis resistance. This cancer-like phenotype promoted increased cytosolic calcium ([Ca2+]cyto), aerobic glycolysis, mitochondrial fission.Objectives: To determine how changes in uniporter (MCU) complex (MCUC) function influence dynamics contribute to PAH’s phenotype.Methods: PASMCs were isolated from patients...

10.1164/rccm.201604-0814oc article EN American Journal of Respiratory and Critical Care Medicine 2016-09-20

Mitotic fission is increased in pulmonary arterial hypertension (PAH), a hyperproliferative, apoptosis-resistant disease. The mediator dynamin-related protein 1 (Drp1) must complex with adaptor proteins to cause fission. Drp1-induced has been therapeutically targeted experimental PAH. Here, we examine the role of 2 recently discovered, poorly understood Drp1 adapter proteins, mitochondrial dynamics 49 and 51 kDa (MiD49 MiD51), normal vascular cells explore their dysregulation PAH.Immunoblots...

10.1161/circulationaha.117.031258 article EN Circulation 2018-02-05

Rationale: Right ventricular (RV) fibrosis in pulmonary arterial hypertension contributes to RV failure. While reflects changes the function of resident fibroblasts (RVfib), these cells are understudied. Objective: Examine role mitochondrial metabolism RVfib human and experimental hypertension. Methods Results: Male Sprague-Dawley rats received monocrotaline (MCT; 60 mg/kg) or saline. Drinking water containing no supplement PDK (pyruvate dehydrogenase kinase) inhibitor dichloroacetate was...

10.1161/circresaha.120.316443 article EN Circulation Research 2020-03-27

Abstract Mitochondrial fission is important in physiological processes, including coordination of mitochondrial and nuclear division during mitosis, pathologic such as the production reactive oxygen species (ROS) cardiac ischemia‐reperfusion injury (IR). mainly mediated by dynamin‐related protein 1 (Drp1), a large GTPase. The GTPase activity Drp1 essential for its fissogenic activity. Therefore, we aimed to identify inhibitors evaluate their anti‐neoplastic cardioprotective properties five...

10.1096/fj.201901467r article EN The FASEB Journal 2019-12-02

It has been reported that Mitofusin2 (Mfn2) inhibits cell proliferation when overexpressed. We wanted to study the role of endogenous Mfn2 in proliferation, along with structural features influence its mitochondrial localization and control proliferation. Mfn2-knockdown clones a B-cell lymphoma line BJAB exhibited an increased rate A 2-fold increase was also observed Mfn2-knockout mouse embryonic fibroblast (MEF) cells as compared wild-type cells, proliferative advantage knockout MEF blocked...

10.1096/fj.13-230037 article EN The FASEB Journal 2013-09-30

Right ventricular (RV) fibrosis contributes to RV failure in pulmonary arterial hypertension (PAH). The mechanisms underlying PAH and the role of fibroblasts (RVfib) are unknown. Activation mitochondrial fission mediator dynamin-related protein 1 (Drp1) dysfunction myocytes through interaction with its binding partner, (Fis1). However, RVfib is

10.3389/fphys.2018.00828 article EN cc-by Frontiers in Physiology 2018-07-10

Impaired mitochondrial fusion, due in part to decreased mitofusin 2 (Mfn2) expression, contributes unrestricted cell proliferation and apoptosis-resistance hyperproliferative diseases like pulmonary arterial hypertension (PAH) non-small lung cancer (NSCLC).We hypothesized that Mfn2 levels are reduced increased proteasomal degradation of triggered by its phosphorylation at serine 442 (S442) investigated the potential kinase mediators.Mfn2 expression was S442 artery smooth muscle cells from...

10.1096/fj.202100361r article EN The FASEB Journal 2021-07-18

Introduction: Group 2 pulmonary hypertension (PH), defined as a mean arterial pressure ≥25 mmHg with elevated capillary wedge >15 mmHg, has no approved therapy and patients often die from right ventricular failure (RVF). Alterations in mitochondrial metabolism, notably impaired glucose oxidation, increased fission, contribute to ventricle (RV) dysfunction PH. We hypothesized that the impairment of RV left (LV) function group PH results part proglycolytic isoform switch pyruvate kinase muscle...

10.3389/fcvm.2018.00195 article EN cc-by Frontiers in Cardiovascular Medicine 2019-01-24

Drp1 (dynamin-related protein 1), a large GTPase, mediates the increased mitochondrial fission, which contributes to hyperproliferation of pulmonary artery smooth muscle cells in arterial hypertension (PAH). We developed potent GTPase inhibitor, Drpitor1a, but its specificity, pharmacokinetics, and efficacy PAH are unknown.

10.1161/hypertensionaha.124.22822 article EN Hypertension 2024-08-20

Excessive proliferation and apoptosis-resistance are hallmarks of cancer. Increased dynamin-related protein 1 (Drp1)-mediated mitochondrial fission is one the mediators this phenotype. Mitochondrial that accompanies nuclear division called mitotic occurs when activated Drp1 binds partner proteins on outer membrane. We examine role Drp1-binding partners, dynamics 49 51 kDa (MiD49 MiD51), as drivers cell in non-small lung cancer (NSCLC) invasive breast carcinoma (IBC). also evaluate whether...

10.1096/fj.201903117r article EN The FASEB Journal 2020-02-18

Mitofusin 2 (Mfn2), a mitochondrial protein, was shown to have antiproliferative properties when overexpressed. In this article, we show that activation of resting human peripheral blood T cells caused downregulation Mfn2 levels. This blocked by different inhibitors (mTOR inhibitor rapamycin, PI3K LY294002, and Akt A443654), producing were arrested in the G0/G1 stage cell cycle. Furthermore, activation-induced preceded entry into cycle, suggesting is prerequisite for activated Accordingly,...

10.4049/jimmunol.1501023 article EN The Journal of Immunology 2015-11-14

Group 2 pulmonary hypertension (PH) has no approved PH-targeted therapy. Metabolic remodelling, specifically a biventricular increase in pyruvate kinase muscle (PKM) isozyme to 1 ratio, occurs rats with group PH induced by supra-coronary aortic banding (SAB). We hypothesize that increased PKM2/PKM1 is maladaptive and inhibiting PKM2 would improve right ventricular (RV) function.Male, Sprague-Dawley SAB were confirmed have echocardiography then randomized treatment inhibitor (intraperitoneal...

10.1111/apha.13764 article EN Acta Physiologica 2022-01-03
Coming Soon ...